NEW YORK - Another piece of good news about a recently approved drug for type 2 diabetes is that it is very effective in treating heart failure and can even reverse the damage in some cases. Its positive effects have been seen in diabetics and heart patients alike.
Scientists at the Icahn School of Medicine at Mount Sinai Hospital say that ampa-glyphosine, sold under the name Jordians, not only increases the size, shape and function of the heart but also increases exercise if the patient consults with a physician. Can improve the quality of life.
This reduces the number of frequent hospitalizations for heart failure patients. The study was summarized three days ago at the American Heart Association's Scientific Meeting for 2020 and was published at the American College of Cardiology.
When the heart starts to grow, its mass increases and it comes to a constant state of rapid heartbeat, then some tests confirm this. In this disease, the heart moves towards the failure of its functions and life becomes difficult. The study was led by Carlos Santos Gallego, who says the drug improves heart function, which has not been fully understood.
On the other hand, it is also an excellent prescription for patients with diabetes. Currently, the study included 84 people who were suffering from chronic heart failure and their condition was deteriorating. His heart rate (EF) was very low and was declining further.
When they were given ampicillin for six months, 80% of the patients improved, while the rate was much lower in patients with placebo.
0 Comments
Please don't enter any spam link in the comment box. Thanks